Formulary Watch Spotlights
Product Profile: LYNOZYFIC (linvoseltamab-gc)
Product Profile: LIBTAYO (cemiplimab)
Product Profile: JASCAYD (nerandomilast)
Product Profile: JOURNAVX (suzetrigine)
Product Profile: MONJUVI (tafasitamab-cxix injection, for intravenous use)
Product Profile: ZYNYZ (retifanlimab-dlwr injection, for intravenous use)
Product Profile: REXULTI (brexpiprazole tablet)
Product Profile: MIEBO (perfluorohexyloctane ophthalmic solution)
Product Profile: EYELEA HD (aflibercept injection, solution)
Product Profile: TARPEYO (budesonide capsule, delayed release)
Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Product Profile: XDEMVY (lotilaner ophthalmic solution)
Product Profile: ABILIFY ASIMTUFII (aripiprazole injection, suspension, extended release)
Product Profile: AREXVY (respiratory syncytial virus vaccine, adjuvanted)
Product Profile: ABRYSVO (respiratory syncytial virus vaccine)
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Rural health is ailing. Is $50 billion enough to heal it?
2
Recombinant shingles vaccine linked to lower cardiovascular disease risk
3
Real-World Safety Experience and Clinical Takeaways from the BE BOLD Trial
4
GLP-1 medications are linked to hair loss in Type 2 diabetes
5